On Tuesday 26th September we hosted our UK Sterilization Technical Seminar at the Woodland Grange Hotel in Royal Leamington Spa, UK. More than 30 delegates joined us to learn about changes to EU Medical Device Regulations and ISO 13485:2016, and broaden their knowledge of the complete sterilization service offered by STERIS AST and Laboratories
STERIS is pleased to announce the acquisition of Harwell Dosimeters Limited, which will become a part of our STERIS Applied Sterilization Technologies (AST) business. Founded in 1960, Harwell is based in Didcot, Oxfordshire, United Kingdom and is recognized for quality products and its Customer service capabilities.
STERIS Applied Sterilization Technologies (AST) has announced several expansion projects over the past year throughout our global sterilization and laboratory network. We’re excited to provide updates on these projects as part of our commitment to providing both global and local Customers with processing capacity.
We are pleased to announce the installation of an upgraded Operations Data Management System (ODMS) at all STERIS Applied Sterilization Technologies (AST) sites worldwide.
Originally opened in March 2016, the STERIS Laboratories facility in Radeberg, Germany offers testing support and validation aligned with ISO11137 – including aging, bioburden, endotoxin, environmental and sterility tests for medical device and pharmaceutical Customers.
Earlier this year, STERIS Applied Sterilization Technologies (AST) announced several expansion projects throughout our global sterilization and laboratory network. We’re excited to provide updates on these projects as part of our commitment to providing both global and local Customers with processing capacity.
Earlier this year, we announced the new brand for our sterilization services, STERIS Applied Sterilization Technologies (AST). We are now excited to announce that, effective February 15, 2017, the new brand for our laboratory offering is STERIS Laboratories.
We’re happy to publish the Application Note concerning the research carried out by our team at the Pharmaceutical Testing Laboratory in Utrecht, in conjunction with colleagues at the STERIS Gamma Sterilisation site in Ede, NL and the Bruker research lab in Bremen, on irradiated Oxybutynine
The recent combination of STERIS Corporation and Synergy Health has created a leading global service supplier, providing Customers with a network of over 50 contract sterilization and laboratory facilities worldwide. As a combined organization, STERIS Applied Sterilization Technologies (AST) is committed to providing both global and local Customers with processing capacity through various technologies worldwide.
On Tuesday 8th March Synergy Health, now part of STERIS team celebrated the opening of their brand new microbiological laboratory in Radeberg, Germany. This adds to the current network of STERIS Pharmaceutical Laboratories in the UK, Ireland, Netherlands, Italy and Czech Republic.